ArticleOncotarget2017
Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.
Chin-Hsiao TsengPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ArticleOncotarget2017
Chin-Hsiao TsengPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.